Nanoparticle |
PLGA |
Camptothecin |
Improved median survival (22 days vs. 15 days) with 30% long-term survivors in 9L rat model |
[23] |
PLGA |
Carboplatin |
Increased tumor cytotoxicity, reduced neurotoxicity, increased retention in rat and porcine models |
[24] |
PLGA |
Dithiazanine iodide |
Brain-penetrating NPs inhibited growth of brain cancer stem cells and provided survival benefit in rats |
[12] |
PEG-PLGA |
Paclitaxel |
PEGylated NPs provided enhanced distribution and tumor growth suppression in 9L rat model |
[30] |
PEG-poly(aspartic acid) |
Cisplatin |
Reduced neurotoxicity of cisplatin with controlled release, and significantly enhanced survival (80% long-term survivors) |
[31] |
Squalenoyl-PEG |
Gemcitabine |
PEGylated squalene NPs provided radiosensitization and survival benefit in RG2 rat model |
[32] |
Poly(β-aminoester) |
HSV thymidine kinase DNA |
Achieved intratumoral transfection with and extended survival in 9L rat model |
[35] |
PEG-poly-L-lysine |
DNA |
PEGylation of NPs improved distribution and efficient transfection in vivo |
[38] |
Fe(Salen) |
- |
Combination with alternating magnetic field exposure provided greater anti-tumor effect (combined hyperthermia-chemotherapy) |
[41] |
PLGA |
SPIO |
Enabled visualization of NP distribution in the rat brain by MRI, with long-lasting signal attenuation |
[49] |
PEG-PLA-PCL |
Temozolomide, magnetite |
Multifunctional NPs were used to monitor NP distribution with MRI and prolonged survival of mice with U87 intracranial tumors |
[52] |
Iron oxide |
EGFRvIII antibody |
Provided selective MRI contrast enhancement of tumor cells and targeted therapy in mouse model |
[101] |
Liposome |
Dioleoyl lecithin, cholesterol, PEG2000 PE |
Gadolinium |
Enabled in vivo monitoring of complete tumor coverage and co-infusion with Doxil |
[46] |
DSPC, cholesterol, PEG2000 PE |
Irinotecan |
Showed greater anti-tumor activity and survival benefit with CED of liposomal irinotecan plus radiation in mouse model |
[26] |
DSPC, cholesterol |
Rhenium-186 |
Real-time visualization by SPECT; brachytherapy resulted in enhanced median survival (126 days vs. 49 days) in rat model |
[39] |
DOPC, cholesterol, PEG-DSG |
Gadolinium |
CED and real-time MRI monitoring allowed visualization of distribution in non-human primate brain |
[47] |
PEG-transferrin |
Sodium borocaptate, lomeprol |
Targeted boron to tumor tissue and enabled real-time CT imaging, with signal lasting over 72h |
[54] |
Lipidoid telodendrimer |
Lipid-polymer hybrid |
Truncated diphtheria toxin |
Improved intratumoral distribution; achieved delivery of active proteins and tumor growth inhibition in mice with U87 tumors |
[29] |
Lipid nanocapsule |
Chitosan |
siRNAs against Galectin-1 and EGFR |
Combination therapy of siRNA-LNCs and TMZ enhanced survival of mice with U87 tumors |
[36] |
Lipoid |
Rhenium-188 |
Internal radiotherapy enhanced survival in mice witih orthotopic GBM tumors (50% long-term survivors) |
[40] |
Nanodiamond |
Diamond |
Doxorubicin |
Enhanced DOX retention, localized toxicity and prolonged survival in rat model |
[27] |
Micelle |
Poloxamer407 |
Panobinostat |
100% survival after a single infusion in F89 rat model |
[28] |
PEG-poly(glutamic acid) |
SN-38 |
Enhanced distribution and median survival in rat models, with minimal neurotoxicity |
[53] |